Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects

NCT03687684 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-831
DRUG: Placebo

Sponsor

Neurocrine Biosciences

Collaborators

[object Object]